1 story in the last 7 days
The latest gammatile news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks gammatile across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.

GT Medical Technologies raised $100 million in Series E funding led by Viking Global Investors to advance GammaTile brain tumour therapy. Funds support commercial rollout, clinical trial expansion, and operational growth. GammaTile delivers targeted radiation via bioresorbable collagen with Cesium-131 seeds during surgery, reducing recurrence and side effects.
Summaries by ByteBrief